A prospective case-control study of 150 participants found circulating cell-free DNA distinguished ovarian cancer from benign ...
The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...
Tests that detect abnormal cancer genes (DNA) circulating freely in the blood to identify nearly 50 types of cancer early are ...
New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...
Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...
CHARLOTTE, N.C. — Circulating tumor DNA (ctDNA) from patients with gastrointestinal (GI) cancers can reflect treatment response, spare some additional treatment, or signal potential remission in those ...
Source: Getty Images A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy. [Editor’s note: This article was updated in June 2026 from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results